SCHEMBL23487538

SCHEMBL23487538

Clc1cc(-c2ccccc2-c2ccccc2)cc(-c2ccccc2-c2ccccc2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.54
CYP1A2 P05177 1/20 0.46
BACE1 P56817 1/20 0.44
METAP2 P50579 1/20 0.43
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 2/20 0.42
HPGD P15428 1/20 0.42
BCL2L1 Q07817 1/20 0.42
MAPK1 P28482 1/20 0.42
ABL1 P00519 1/20 0.41
ABCB1 P08183 1/20 0.41
BCR P11274 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
PTPRC P08575 1/20 0.41
TSHR P16473 2/20 0.41
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31720941 0.93 CYP1A2 (0.52) CYP2A6CYP1A2BACE1METAP2ALDH1A1
SCHEMBL31369120 0.86 LMNA (0.44) CYP2A6CYP1A2METAP2ALDH1A1HPGD
SCHEMBL26204709 0.85 CYP2A6 (0.45) CYP2A6CYP1A2BACE1METAP2ALDH1A1
SCHEMBL5050877 0.83 CYP2A6 (0.52) CYP2A6CYP1A2TSHRSMN1; SMN2NPC1
SCHEMBL20007057 0.82 PTGS2 (0.47) ALDH1A1ABL1ABCB1BCRPTGS2
SCHEMBL19533270 0.82 CYP1A2 (0.44) CYP2A6CYP1A2BACE1METAP2ALDH1A1
SCHEMBL23487648 0.82 CNR1 (0.48) CYP1A2METAP2CNR1
SCHEMBL24780597 0.81 CYP1A2 (0.60) CYP2A6CYP1A2ALDH1A1HPGDTSHR
SCHEMBL1959308 0.81 CYP1A2 (0.60) CYP2A6CYP1A2ALDH1A1HPGDTSHR
SCHEMBL20081661 0.81 CYP1A2 (0.60) CYP2A6CYP1A2ALDH1A1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230056324-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2023-02-23 US disclosed
WO-2021110720-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2021-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230056324-A1 METAL COMPLEXES MCU, IMMT, SOD1 CYP2A6 4118/4885CYP1A2 2830/4885BACE1 3559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.